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Abstract
[99mTc]MIBI thyroid scintigraphy is a useful tool to differentiate benign from malignant thyroid nodules. This report aims to 
show the diagnostic performance of [99mTc]MIBI scintigraphy used in an 83-year-old woman who had a thyroidectomy about 
7 years ago. She had a mass of thyroid which was very large, non-homogenous and painless. [99mTc]MIBI scintigraphy could 
be a pre-surgical method to investigate the follicular nodules and predicting the malignant form of thyroid nodules. Also, it will 
provide tissue information for [99mTc]MIBI images in thyroid lesions.
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The prevalence of thyroid nodules is about 5% even in areas with 
adequate iodine intake [1]. The risk of thyroid nodules is about 3–5% 
[2]. Thyroid cancer has been one of the most diagnosed forms of 
cancers around the world in the past few decades [3]. The 2nd most 
common thyroid cancer is follicular thyroid cancer, and it is a higher 
incidence of distant metastases. Therefore, the prognosis is worse than 
the more common papillary thyroid carcinoma [4–6]. Thyroid gland 
follicular neoplasm comprises follicular carcinoma and adenoma. 
Case presentation
An 83-year-old woman came for a nuclear thyroid scan. After 
examination of her neck, the mass of thyroid was non-homogenous, 
enlarged, difficult to be examined and firm and painless. She had 
a thyroidectomy 7 years ago but did not know the details of whether 
it was a total or hemithyroidectomy. After 4 years of recurrence, 
the physician advised her to have another surgery, but the patient 
was not satisfied. After scanning of the patient’s thyroid with [99mTc]
pertechnetate, it was observed that this mass had no uptake, 
Therefore, performing a [99mTc]MIBI was decided. In this case report 
were performed both [99mTc]pertechnetate and 99mTC-MIBI scintig-
raphy in anterior projection. The study showed poor delineation of 
the thyroid gland in [99mTc]pertechnetate thyroid scan (Fig. 1). In the 
[99mTc]MIBI scan, an area of increased uptake is noticed on the left 
lobe of the thyroid corresponding to a palpable nodule. The left 
lobe of the thyroid was enlarged with a rather in-homogenous ra-
diotracer uptake. There was no significant radiotracer activity in 
the right lobe of the thyroid (due to previous surgery) (Fig. 2). With 
the patient’s history (previous thyroidectomy), scan findings (MIBI 
avid lesions of the left lobe) showed highly tumour recurrence and 
after following up she was diagnosed with follicular carcinoma.  
[99mTc]MIBI and [99mTc]pertechnetate 
scintigraphy 
Twenty minutes after IV injection of 111 MBQ (3 MCI) [99mTc]
pertechnetate and twenty minutes after IV injection of 148 MBQ 
(4 MCI) [99mTc]MIBI, thyroid imaging was performed in anterior 
projection.
Discussion
[99mTc]MIBI scans have been used to study myocardial perfu-
sion since 1989, but the uptake of this radiopharmaceutical into 
tumours has led to its use in the study of breast, bone, thyroid, 
parathyroid, and brain tumours [7]. Numerous studies examining 
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Clinical 
vignette
thyroid scans with [99mTc]MIBI show conflicting results [8]. 
In a study of 34 operated thyroid nodules, it was concluded that 
the rate of absorption of [99mTc]MIBI in the thyroid nodule is mainly 
a sign of thyroid tissue viability and is not specific to malignancy 
[9]. But another study [7] on thyroid nodules found that high up-
take of [99mTc]MIBI significantly increased the risk of malignancy. 
The researchers suggested routine use of [99mTc]MIBI scan with 
fine-needle aspiration in the diagnosis of cold thyroid.
Nowadays, fewer than 25% of nodules (follicular neoplasm) 
show malignant features at histological examination [10, 11]. 
Some studies expressed that [99mTc]MIBI scintigraphy is a reliable 
procedure to improve the accuracy of diagnostic thyroid fine-needle 
aspiration cytology (FNAC) [2, 12 13]. Several authors observed that 
[99mTc]MIBI scintigraphy is positive in both malignant and benign 
thyroid lesions [13, 14] and [99mTc]MIBI thyroid scintigraphy is highly 
accurate in the differential diagnosis of nodules with indeterminate 
cytology finding [15].
We can conclude that [99mTc]MIBI scintigraphy could be 
a pre-surgical method to investigate follicular nodules and pre-
dicting the malignant thyroid nodules. Therefore, the scintigraphy 
of [99mTc]MIBI provides tissue information for these scintigraphy 
images in thyroid nodules. 
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